Hookipa Pharma

IPO

Hookipa Pharma is a biotech company in New York, United States, founded in 2011. It has raised $159.8M across 5 rounds, most recently a $21.3M Corporate Round in December 2023.

Headquarters
New York, New York
Employees
51–200
Founded
2011
Business Model
B2B
Total Funding
$159.8M
Last Round
$21.3M Corporate RoundDec 2023
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 9 investors for this company. The full record is or through the API.

About

HOOKIPA Pharma (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing immunotherapy through proprietary arenavirus vector platforms. Its replication-restricted and replication-competent arenaviral vectors are engineered to generate strong and durable T-cell responses, addressing cancers and chronic infectious diseases such as HIV. The company's pipeline includes HB-200 (HPV16+ head and neck cancer, in combination with pembrolizumab) and HB-300 (prostate cancer targeting self-antigens), both in Phase 2 trials. Founded in 2011 and headquartered in New York City, HOOKIPA was spun out of leading academic research and has raised approximately $160M to advance its novel immunotherapy pipeline.

Summary

It lists 51–200 employees. It has raised $159.8M in total across 5 rounds, most recently a $21.3M Corporate Round in Dec 2023. Investors include Redmile Group, Forbion Capital Partners and Sofinnova Partners.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundDec 2023
$21.3M

Sign up to see all 6 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hookipa Pharma on Indexed.vc
<a href="https://indexed.vc/companies/hookipa-pharma"><img src="https://indexed.vc/api/badge/company/hookipa-pharma" alt="Hookipa Pharma on Indexed.vc" width="260" height="76" /></a>